0

Butaclamol Hydrochloride in Newly Admitted Schizophrenics

L E Hollister, K L Davis, P A Berger

Psychopharmacol Commun. 1975;1(5):493-500.

PMID: 778939

Abstract:

Butaclamol hydrochloride, a new type of antipsychotic drug, was evaluated by an uncontrolled study of 13 newly admitted schizophrenic patients. The drug had antipsychotic effects as well as a strong propensity for evoking extrapyramidal side effects. With the maximal daily doses of 30 mg used in this study, therapeutic results obtained were probably somewhat less than optimal.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP55528079 (+)-Butaclamol hydrochloride (+)-Butaclamol hydrochloride 55528-07-9 Price
qrcode